Bay Area biotech files plans for IPO as it works to treat lung-scarring disease
May 11, 2020 at 10:19 AM EDT
The South San Francisco company hopes to follow in the footsteps of three other Bay Area life science companies who have had strong debuts on Wall Street this year which has been dominated by offerings from that sector in its first four months.